{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:43:27Z","timestamp":1791848607530,"version":"4.3.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajpm-online.net","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Medicine"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.amepre.2020.09.005","type":"journal-article","created":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T18:34:12Z","timestamp":1608230052000},"page":"387-396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Geographic Variation in Human Papillomavirus Vaccination Initiation and Completion Among Young Adults in the U.S."],"prefix":"10.1016","volume":"60","author":[{"given":"Eric","family":"Adjei Boakye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwole A.","family":"Babatunde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maggie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nosayaba","family":"Osazuwa-Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiley","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10 suppl","key":"10.1016\/j.amepre.2020.09.005_bib0001","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1002\/cncr.23764","article-title":"HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women","volume":"113","author":"Gillison","year":"2008","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.amepre.2020.09.005_bib0002","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/jamaoto.2018.0993","article-title":"Incidence and risk of second primary malignant neoplasm after a first head and neck squamous cell carcinoma","volume":"144","author":"Adjei Boakye","year":"2018","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"5","key":"10.1016\/j.amepre.2020.09.005_bib0003","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.1999","article-title":"Trends in risks for second primary cancers associated with index human papillomavirus-associated cancers","volume":"1","author":"Suk","year":"2018","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.amepre.2020.09.005_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2019.101649","article-title":"Risk of subsequent malignant neoplasms after an index potentially-human papillomavirus (HPV)-associated cancers","volume":"64","author":"Wang","year":"2020","journal-title":"Cancer Epidemiol"},{"issue":"32","key":"10.1016\/j.amepre.2020.09.005_bib0005","doi-asserted-by":"crossref","first-page":"698","DOI":"10.15585\/mmwr.mm6832a3","article-title":"Human papillomavirus vaccination for adults: updated recommendations of the Advisory Committee on Immunization Practices","volume":"68","author":"Meites","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.amepre.2020.09.005_bib0006","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/0009922816660541","article-title":"Human papillomavirus vaccination and age at first sexual activity, National Health and Nutrition Examination Survey","volume":"56","author":"Petrosky","year":"2017","journal-title":"Clin Pediatr (Phila)"},{"issue":"33","key":"10.1016\/j.amepre.2020.09.005_bib0007","doi-asserted-by":"crossref","first-page":"909","DOI":"10.15585\/mmwr.mm6733a1","article-title":"National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years - United States, 2017 [published correction appears in MMWR Morb Mortal Wkly Rep. 2018;67(41):1164]","volume":"67","author":"Walker","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"8","key":"10.1016\/j.amepre.2020.09.005_bib0008","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1080\/21645515.2018.1467203","article-title":"Correlates of human papillomavirus (HPV) vaccination initiation and completion among 18-26 year olds in the United States","volume":"14","author":"Adjei Boakye","year":"2018","journal-title":"Hum Vaccin Immunother"},{"issue":"47","key":"10.1016\/j.amepre.2020.09.005_bib0009","doi-asserted-by":"crossref","first-page":"5495","DOI":"10.1016\/j.vaccine.2013.09.022","article-title":"Geographic variation in human papillomavirus vaccination uptake among young adult women in the United States during 2008-2010","volume":"31","author":"Rahman","year":"2013","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.amepre.2020.09.005_bib0010","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s10900-015-9995-2","article-title":"Differences in HPV immunization levels among young adults in various regions of the United States","volume":"40","author":"Rahman","year":"2015","journal-title":"J Community Health"},{"issue":"12","key":"10.1016\/j.amepre.2020.09.005_bib0011","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.4161\/21645515.2014.980202","article-title":"Regional variations in HPV vaccination among 9-17 year old adolescent females from the BRFSS, 2008-2010","volume":"10","author":"Hirth","year":"2014","journal-title":"Hum Vaccin Immunother"},{"issue":"24","key":"10.1016\/j.amepre.2020.09.005_bib0012","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1016\/j.vaccine.2012.03.067","article-title":"An update on human papillomavirus vaccine uptake among 11-17 year old girls in the United States: National Health Interview Survey, 2010","volume":"30","author":"Laz","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.amepre.2020.09.005_bib0013","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.amepre.2012.09.061","article-title":"Geographic variability in human papillomavirus vaccination among U.S. young women","volume":"44","author":"Wei","year":"2013","journal-title":"Am J Prev Med"},{"issue":"24","key":"10.1016\/j.amepre.2020.09.005_bib0014","doi-asserted-by":"crossref","first-page":"5612","DOI":"10.1002\/cncr.26246","article-title":"Human papillomavirus vaccine uptake among 9- to 17-year-old girls: National Health Interview Survey, 2008","volume":"117","author":"Wong","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.amepre.2020.09.005_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pvr.2015.10.001","article-title":"HPV vaccine completion and dose adherence among commercially insured females aged 9 through 26 years in the U.S","volume":"2","author":"Liu","year":"2016","journal-title":"Papillomavirus Res"},{"issue":"32","key":"10.1016\/j.amepre.2020.09.005_bib0016","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","article-title":"Human papillomavirus and rising oropharyngeal cancer incidence in the United States","volume":"29","author":"Chaturvedi","year":"2011","journal-title":"J Clin Oncol"},{"issue":"22","key":"10.1016\/j.amepre.2020.09.005_bib0017","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1158\/1078-0432.CCR-09-0784","article-title":"Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications","volume":"15","author":"Chung","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"26","key":"10.1016\/j.amepre.2020.09.005_bib0018","doi-asserted-by":"crossref","first-page":"661","DOI":"10.15585\/mmwr.mm6526a1","article-title":"Human papillomavirus-associated cancers - United States, 2008-2012","volume":"65","author":"Viens","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"33","key":"10.1016\/j.amepre.2020.09.005_bib0019","doi-asserted-by":"crossref","first-page":"874","DOI":"10.15585\/mmwr.mm6633a2","article-title":"National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years - United States, 2016","volume":"66","author":"Walker","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.amepre.2020.09.005_bib0020","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1146\/annurev.publhealth.031308.100226","article-title":"The Behavioral Risk Factors Surveillance System: past, present, and future","volume":"30","author":"Mokdad","year":"2009","journal-title":"Annu Rev Public Health"},{"issue":"3","key":"10.1016\/j.amepre.2020.09.005_bib0021","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/ajt.14206","article-title":"Use of a 2-dose schedule for human papillomavirus vaccination\u2013updated recommendations of the Advisory Committee on Immunization Practices","volume":"17","author":"Meites","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.amepre.2020.09.005_bib0022","unstructured":"Regional offices. Office of Intergovernmental and External Affairs. HHS. https:\/\/www.hhs.gov\/about\/agencies\/iea\/regional-offices\/index.html. Updated April 15, 2014. Accessed January 31, 2020."},{"key":"10.1016\/j.amepre.2020.09.005_bib0023","article-title":"Differences in human papillomavirus (HPV) vaccine uptake by nativity status among men aged 18-34 years","volume":"16","author":"Adjei Boakye","year":"2019","journal-title":"Prev Med Rep"},{"issue":"25","key":"10.1016\/j.amepre.2020.09.005_bib0024","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1016\/j.vaccine.2020.03.059","article-title":"Regional variation in human papillomavirus vaccination uptake and completion among adolescents 13-17 in the state of Texas","volume":"38","author":"Conrey","year":"2020","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.amepre.2020.09.005_bib0025","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1016\/j.vaccine.2020.01.053","article-title":"Awareness and knowledge of HPV and HPV vaccination among adults ages 27-45 years","volume":"38","author":"Thompson","year":"2020","journal-title":"Vaccine"},{"issue":"30","key":"10.1016\/j.amepre.2020.09.005_bib0026","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1016\/j.vaccine.2019.06.001","article-title":"Regional variations in human papillomavirus prevalence across time in NHANES (2003-2014)","volume":"37","author":"Hirth","year":"2019","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.amepre.2020.09.005_bib0027","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1158\/1055-9965.EPI-17-0430","article-title":"Rural-urban differences in cancer incidence and trends in the United States","volume":"27","author":"Zahnd","year":"2018","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.amepre.2020.09.005_bib0028","series-title":"HHS, Centers for Disease Control and Prevention and National Cancer Institute","year":"2020"},{"issue":"2","key":"10.1016\/j.amepre.2020.09.005_bib0029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172548","article-title":"Recent trends in racial and regional disparities in cervical cancer incidence and mortality in United States","volume":"12","author":"Yoo","year":"2017","journal-title":"PLoS One"},{"issue":"44","key":"10.1016\/j.amepre.2020.09.005_bib0030","first-page":"1004","article-title":"Vital signs: cervical cancer incidence, mortality, and screening - United States, 2007-2012","volume":"63","author":"Benard","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.amepre.2020.09.005_bib0031","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/sti.76.4.257","article-title":"A longitudinal study of HPV detection and cervical pathology in HIV infected women","volume":"76","author":"Cubie","year":"2000","journal-title":"Sex Transm Infect"},{"issue":"1","key":"10.1016\/j.amepre.2020.09.005_bib0032","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1158\/1055-9965.EPI-11-0734","article-title":"Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults","volume":"21","author":"Beachler","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.amepre.2020.09.005_bib0033","series-title":"Centers for Disease Control and Prevention","year":"2020"},{"issue":"1","key":"10.1016\/j.amepre.2020.09.005_bib0034","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/vaccines5010008","article-title":"The cost of cost-sharing: the impact of Medicaid benefit design on influenza vaccination uptake","volume":"5","author":"Stoecker","year":"2017","journal-title":"Vaccines (Basel)"},{"issue":"2","key":"10.1016\/j.amepre.2020.09.005_bib0035","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1377\/hlthaff.24.2.317","article-title":"Racial and ethnic health disparities and the unfinished civil rights agenda","volume":"24","author":"Smith","year":"2005","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.amepre.2020.09.005_bib0036","series-title":"Centers for Disease Control and Prevention","year":"2016"},{"key":"10.1016\/j.amepre.2020.09.005_bib0037","unstructured":"The Merck patient assistance programs helps those in need. Merck Helps. https:\/\/www.merckhelps.com\/Home.aspx. Accessed January 28, 2020."},{"issue":"4","key":"10.1016\/j.amepre.2020.09.005_bib0038","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/jrh.12353","article-title":"HPV vaccination coverage among U.S. teens across the rural-urban continuum","volume":"35","author":"Swiecki-Sikora","year":"2019","journal-title":"J Rural Health"},{"key":"10.1016\/j.amepre.2020.09.005_bib0039","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ypmed.2018.01.016","article-title":"Rural-urban differences in human papillomavirus knowledge and awareness among U.S. adults","volume":"109","author":"Mohammed","year":"2018","journal-title":"Prev Med"},{"issue":"9","key":"10.1016\/j.amepre.2020.09.005_bib0040","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1080\/10810730.2017.1347216","article-title":"Racial and ethnic differences in tobacco information seeking and information sources: findings from the 2015 Health Information National Trends Survey","volume":"22","author":"Nguyen","year":"2017","journal-title":"J Health Commun"},{"key":"10.1016\/j.amepre.2020.09.005_bib0041","unstructured":"National Conference of State Legislatures. HPV vaccine: state legislation and regulation. Denver, CO: National Conference of State Legislatures.https:\/\/www.ncsl.org\/research\/health\/hpv-vaccine-state-legislation-and-statutes.aspx. Accessed January 31, 2020."},{"issue":"5","key":"10.1016\/j.amepre.2020.09.005_bib0042","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jadohealth.2016.06.005","article-title":"Disparities in provider recommendation of human papillomavirus vaccination for U.S. adolescents","volume":"59","author":"Mohammed","year":"2016","journal-title":"J Adolesc Health"},{"issue":"33","key":"10.1016\/j.amepre.2020.09.005_bib0043","doi-asserted-by":"crossref","first-page":"724","DOI":"10.15585\/mmwr.mm6833a3","article-title":"Human papillomavirus\u2013attributable cancers - United States, 2012\u20132016","volume":"68","author":"Senkomago","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["American Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379720304323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379720304323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T07:59:19Z","timestamp":1760083159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749379720304323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0749379720304323"],"URL":"https:\/\/doi.org\/10.1016\/j.amepre.2020.09.005","relation":{},"ISSN":["0749-3797"],"issn-type":[{"value":"0749-3797","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Geographic Variation in Human Papillomavirus Vaccination Initiation and Completion Among Young Adults in the U.S.","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amepre.2020.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}